Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
0.8000
-0.1399 (-14.88%)
Mar 31, 2025, 3:24 PM EDT - Market open

Company Description

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.

It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.

The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories.

Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

Adagio Medical Holdings, Inc.
Adagio Medical Holdings logo
Country United States
Founded 2011
Industry Medical Devices
Sector Healthcare
Employees 85
CEO Todd Usen

Contact Details

Address:
26051 Merit Circle, Suite 102
Laguna Hills, California 92653
United States
Phone 949-348-1188
Website adagiomedical.com

Stock Details

Ticker Symbol ADGM
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002006986
CUSIP Number 00534B100
ISIN Number US00534B1008
SIC Code 3841

Key Executives

Name Position
Todd Usen Chief Executive Officer and Director
Olav B. Bergheim Advisor
Dr. Alex Babkin Ph.D. Chief Technical Officer
Nabil Jubran Chief Compliance Officer
Ilya Grigorov Vice President of Global Marketing and Product Management

Latest SEC Filings

Date Type Title
Mar 27, 2025 424B3 Prospectus
Mar 27, 2025 424B3 Prospectus
Mar 27, 2025 10-K Annual Report
Mar 27, 2025 S-8 Securities to be offered to employees in employee benefit plans
Mar 17, 2025 424B3 Prospectus
Mar 17, 2025 424B3 Prospectus
Mar 17, 2025 8-K Current Report
Mar 4, 2025 424B3 Prospectus
Mar 4, 2025 424B3 Prospectus
Mar 4, 2025 8-K Current Report